Edesa Biotech to present kidney injury drug data at European conference

May 19, 2026 9:15 AM

Edesa Biotech Inc. (NASDAQ: EDSA) will present data on its experimental drug paridiprubart for acute kidney injury at the 63rd ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found